2021 | Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer | Wu, Heng-Hsiung; Tsai, Lung-Hung; Huang, Chun-Kai; Hsu, Pang-Hung; Chen, Mei-Yu; Chen, Yi-Ing; Hu, Chun-Mei; Shen, Chia-Ning; Lee, Chen-Chen; MING-CHU CHANG ; YU-TING CHANG ; YU-WEN TIEN ; YUNG-MING JENG ; Lee, Eva Y-H P; Lee, Wen-Hwa | Science translational medicine | 12 | 11 | |
2024 | Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy | Huang, Yu-Kai; Cheng, Wei-Chung; Kuo, Ting-Ting; Yang, Juan-Cheng; Wu, Yang-Chang; Wu, Heng-Hsiung; Lo, Chia-Chien; Hsieh, Chih-Ying; Wong, Sze-Ching; Lu, Chih-Hao; Wu, Wan-Ling; Liu, Shih-Jen; Li, Yi-Chuan; Lin, Ching-Chan; Shen, Chia-Ning; Hung, Mien-Chie; JAW-TOWN LIN ; Yeh, Chun-Chieh; Sher, Yuh-Pyng | Nature cancer | | | |